VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1035757
Sex: U
Age:
State: MN

Vax Date:
Onset Date:
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation, referring to a currently 72-year-old patient of unknown gender. In or about 2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and/or zoster-related conditions (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported). On an unknown date, reported as subsequent to the vaccination, the patient was treated for the following injury resulted from zoster vaccine live (ZOSTAVAX) used: shingles. The outcome of herpes zoster was not reported. The reporter considered herpes zoster to be related to zoster vaccine live (ZOSTAVAX).

Other Meds:

Current Illness:

ID: 1035758
Sex: U
Age: 12
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 12-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions and concomitant therapies were not provided. On 13-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot # T013204 has been verified to be a valid lot number, with expiration date reported as 03-DEC-2021 (strength, exact dose, dose #, anatomical location and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds on 01-JAN-2021. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035759
Sex: U
Age: 2
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 2-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions and concomitant therapies were not provided. On 13-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot # T013204 has been verified to be a valid lot number, with expiration date reported as 03-DEC-2021 (strength, exact dose, dose #, anatomical location and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds on 01-JAN-2021. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035760
Sex: U
Age: 1
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, drug reactions and concomitant therapies were not provided. On 13-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot # T013204 has been verified to be a valid lot number, with expiration date reported as 03-DEC-2021 (strength, exact dose, dose #, anatomical location and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds on 01-JAN-2021. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035761
Sex: U
Age: 1
State: TX

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 16-month-old patient of unknown gender. The patient's pertinent medical history, drug reactions and concomitant therapies were not provided. On 14-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot # T013204 has been verified to be a valid lot number, with expiration date reported as 03-DEC-2021 (strength, exact dose, dose #, anatomical location and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds on 01-JAN-2021. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035762
Sex: U
Age: 2
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 2-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions and concomitant therapies were not provided. On 15-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot # T013204 has been verified to be a valid lot number, with expiration date reported as 03-DEC-2021 (strength, exact dose, dose #, anatomical location and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds on 01-JAN-2021. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035763
Sex: U
Age: 2
State: TX

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 2-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions and concomitant therapies were not provided. On 18-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot # T013204 has been verified to be a valid lot number, with expiration date reported as 03-DEC-2021 (strength, exact dose, dose #, anatomical location and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035764
Sex: U
Age: 8
State: TX

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to an 8-year-old patient of unknown gender. Their concurrent conditions, medical history and concomitant therapies were not provided. On 27-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot number: T013204, expiration date: 03-DEC-2021 (strength, dose, frequency and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035765
Sex: U
Age: 1
State: TX

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 12-month-old patient of unknown gender. Their concurrent conditions, medical history and concomitant therapies were not provided. On 29-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot number: T013204, expiration date: 03-DEC-2021 (strength, dose, frequency and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035766
Sex: U
Age: 1
State: TX

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 20-month-old patient of unknown gender. Their concurrent conditions, medical history and concomitant therapies were not provided. On 29-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot number: T013204, expiration date: 03-DEC-2021 (strength, dose, frequency and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported. This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments: US-009507513-2102USA004059:

Other Meds: VAQTA SYRINGE (DEVICE)

Current Illness:

ID: 1035767
Sex: M
Age: 59
State: MN

Vax Date: 12/15/2020
Onset Date: 12/01/2020
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: ringing in his ears / tinnitus; redness and tenderness at injection site; tenderness at injection site; Lethargy; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of tinnitus (1st dose received on 28th September 2020 and the patient experienced lethargy and redness and tenderness at injection site, refer case US2020252578.). On 15th December 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In December 2020, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site tenderness and lethargy. On 20th December 2020, the patient experienced tinnitus. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site erythema, injection site tenderness and lethargy were recovered/resolved and the outcome of the tinnitus was not recovered/not resolved. The reporter considered the injection site erythema, injection site tenderness and lethargy to be related to Shingrix. It was unknown if the reporter considered the tinnitus to be related to Shingrix. Additional details were provided as follows: The patient received 2nd dose of Shingrix in right deltoid. Lot and expiration date were not known. After receiving 2nd dose of Shingrix, the patient experienced began to experience ringing in his ears which was intermittent and comes and goes, lethargy and redness and tenderness at injection site. The reporter was asking if this was a known side effect. Caller declined to provide contact information for his medical doctor. The reporter did not consent to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2020252578:

Other Meds:

Current Illness:

ID: 1035768
Sex: F
Age: 74
State: TX

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: passed out; urinated on herself; could not sleep; chills; fever; A spontaneous report was received from a consumer concerning a 74 year old female patient who received Moderna's COVID-19 vaccine and experienced loss of consciousness, chills, pyrexia, urinary incontinence and insomnia. The patient's medical history was not provided. Concomitant medication included unspecified blood pressure medications. On an unspecified date, the patient received the first of their first planned doses of mRNA-1273 (lot number unknown) for prophylaxis of COVID-19 infection. On 02-Feb-2021 the patient received the second of their planned doses of mRNA-1273 (Lot number 041L20A) intramuscularly for prophylaxis of COVID-19 infection. On 02-Feb-2020, the patient experienced chills, some fever, and could not sleep. On the morning of 03-Feb-2021, the patient passed out twice and urinated on herself. No treatment information was provided. Action taken with the mRNA-1273 in response to the events was not applicable. The outcome of the events of loss of consciousness, chills, pyrexia, urinary incontinence and insomnia were was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1035769
Sex: M
Age:
State: IN

Vax Date: 01/18/2021
Onset Date: 01/20/2021
Rec V Date: 02/17/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Pneumonia; A spontaneous report received from a healthcare professional concerning a 40-year-old, male patient who received Moderna's COVID-19 vaccine and developed pneumonia. The patient's medical history provided were, severe developmental disabilities, chronic constipation and allergy induced asthma. No relevant concomitant medications were reported. On 18 Jan 2021, patient received their first of two planned doses of mRNA-1273(Lot number: unknown), for the prophylaxis of COVID-19 infection. On 20 Jan 2021, within 3 days after injection, the patient was hospitalized for pneumonia. Patient received the vaccine because he received supported living services. The reporter was reluctant to agree to him receiving the 2nd dose. Treatment for the event was not provided. Action taken the first dose of mRNA-1273 in response to the event was not reported. The outcome of the event pneumonia was unknown.; Reporter's Comments: This case concerns a 40 year old male subject, with history of allergy induced asthma, among others, who experienced a serious unexpected event of pneumonia after first dose of mRNA1273 (Lot# unknown). Very limited information has been provided at this time. Further information has been requested.

Other Meds:

Current Illness: Asthma; Constipation chronic; Disability NOS

ID: 1035770
Sex: F
Age:
State: OH

Vax Date: 01/06/2021
Onset Date: 02/03/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: injection was not given properly in the deltoid and that it was given down, wrong way of administration; Arm started bleeding; A spontaneous report (United States) was received, female consumer who received Moderna's COVID-19 vaccine (mRNA-1273) reported that the injection not given properly in the deltoid (it was given down, wrong way of administration)/incorrect route of product administration and she experienced bleeding of that arm/vaccination site haemorrhage. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 06 Jan 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (LOT 011J20A) intramuscularly for prophylaxis of COVID-19 infection. On 03 Feb 2021, the patient received their second of two planned doses of mRNA-1273 (LOT# 031020A) intramuscularly for prophylaxis of COVID-19 infection. On 03 Feb 2021, the patient reported that the injection was not given properly in the deltoid (it was given down/ wrong way of administration), and her arm started bleeding. The patient received both scheduled doses of mRNA-1273; therefore, action taken with the drug in response to the events is not applicable. The event, injection was not given properly in the deltoid (it was given down/ wrong way of administration), was considered resolved on 03 Feb 2021. The outcome of the event, arm bleeding (at vaccination site), was not reported.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273. Also, based on the current available information and temporal association between the use of the product and the start date of the event of vaccination site hemorrhage, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1035771
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: anaphylaxis; Initial information received on 04-Feb-2021 regarding an unsolicited valid serious case from the other health care professional and issued from a literature article. This case is linked to case 2021SA040002 (same article). This case involves a female patient of unknown age (current age is 55 year) who experienced anaphylaxis (anaphylactic reaction), after she received RABIES VACCINE. Medical history, medical treatment, concomitant medication, vaccination and family history were not provided. On an unknown date, the patient received a dose of suspect RABIES VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for unknown indication. On an unknown date, the patient developed a serious anaphylaxis (anaphylactic reaction), unknown latency following the administration of RABIES VACCINE. This event was assessed as medically significant. It was also reported that the Brighton Collaboration case definition uses combinations of symptoms to define levels of diagnostic certainty. Brighton Level 1 represents the highest level of diagnostic certainty that a reported case is indeed a case of anaphylaxis. All patients should be instructed to seek immediate medical care if they develop signs or symptoms of an allergic reaction after their observation period ends and they have left the vaccination location. Health care providers can play an important role in vaccine safety by being vigilant in recognizing and reporting adverse events after immunization to VAERS. Details of laboratory data not reported. This patient received Pfizer-BioNTech COVID-19 vaccine in Dec-2020 and within 5 minutes experienced anaphylaxis with generalized urticaria, wheezing which required inpatient hospitalization and treatment with EPINEPHRINE. It was unknown if patient received any corrective treatment. At the time of reporting, the outcome of event was reported as unknown. There will be no information available on the batch number for this case.; Sender's Comments: This case involves 55 year old female patient who had anaphylactic reaction after vaccination with RABIES VACCINE (unknown manufacturer). The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.

Other Meds:

Current Illness:

ID: 1035772
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Anaphylaxis; Initial information received on 04-Feb-2021 regarding an unsolicited valid serious case from the other health care professional and issued from a literature article. This case is linked to case 2021SA039986 (same article). This case involves a female patient of unknown age (current age is 44 year) who experienced anaphylaxis (anaphylactic reaction), after she received INFLUENZA VACCINE. Medical history, medical treatment, concomitant medication, vaccination and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for unknown indication. On an unknown date, the patient developed a serious anaphylaxis (anaphylactic reaction), unknown latency following the administration of INFLUENZA VACCINE. This event was assessed as medically significant. It was also reported that the Brighton Collaboration case definition uses combinations of symptoms to define levels of diagnostic certainty. Brighton Level 1 represents the highest level of diagnostic certainty that a reported case is indeed a case of anaphylaxis. All patients should be instructed to seek immediate medical care if they develop signs or symptoms of an allergic reaction after their observation period ends and they have left the vaccination location. Health care providers can play an important role in vaccine safety by being vigilant in recognizing and reporting adverse events after immunization to VAERS (Vaccine Adverse Event Reporting System). Details of laboratory data not reported. This patient received Pfizer-BioNTech COVID-19 vaccine in Dec-2020 and within 34 minutes experienced anaphylaxis with generalized urticaria, swollen lips which required visit emergency department and treatment with Epinephrine. It was unknown if patient received any corrective treatment. At the time of reporting, the outcome of event was reported as unknown. There will be no information available on the batch number for this case.; Sender's Comments: This case involves 44-year-old female patient who had anaphylactic reaction after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.

Other Meds:

Current Illness:

ID: 1035773
Sex: M
Age: 0
State: VA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: were supposed to be given DTaP and IPV separately instead they were given QUADRACEL with no adverse event; Initial information was received on 25-Jan-2021 regarding an unsolicited valid non-serious case from a other health professional. This case is linked to case 2021SA031955 (same reporter). This case involves a 4-month-old male patient who was administered DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot C5755AB, expiry date 10-Jul-2022) via intramuscular route in the right thigh instead they were supposed to administer DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and POLIOMYELITIS VACCINE (INACTIVATED) separately (lot number and expiry date not reported) for prophylactic vaccination on 15-Jan-2021 (wrong product administered). Medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HIB VACCINE CONJ (TET TOX) (HIBERIX); ROTAVIRUS VACCINE (ROTAVIRUS VACCINE); and PNEUMOCOCCAL VACCINE 13V (PNEUMOCOCCAL 13 VALENT VACCINE). This was a case of actual medication error due to wrong vaccine administered (latency same day). At the time of report, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other Meds: HIBERIX; ROTAVIRUS VACCINE; PNEUMOCOCCAL 13 VALENT VACCINE

Current Illness:

ID: 1035774
Sex: F
Age: 100
State: NJ

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Slight rash on upper back, sore throat one evening and eye bacame very red in the corner

Other Meds: Amitriptyline 10MG, Citalopram 40MG, Pantoprazole 40MG, Amlodipine Besylate 2.5MG, Vitamin E 400 IU, Senokot (reg. strength) 1 at bedtime, Colace (reg. strength) 1 at bedtime, Centrum Silver (Women), Blink gel tears eye drops (Night time),

Current Illness:

ID: 1035775
Sex: F
Age: 59
State: MI

Vax Date: 02/03/2021
Onset Date: 02/13/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None

Allergies: Zithromax

Symptoms: February 13, 2021, 10 days after receiving dose one of the Moderna vaccine I began breaking out in hives. I contacted my primary care provider and she suggested Benadryl and Aveeno Oatmeal bath. On February 17, 2021 the hives are still breaking out. I visited my PCP and she increased my dose of Protonix and added Adderax for treatment

Other Meds: Keppra 1000mg Twice Day, Rosuvastatin 20mg Daily, Valtrex 500mg 500mg daily, Vitamin D 50,000 units once a week, Protonix 40mg daily, Metformin 500mg twice daily, Protonix 40mg daily

Current Illness:

ID: 1035776
Sex: F
Age: 61
State:

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Sore arm started about 6 hours after the vaccination and lasting about 24 hours. Fever, chills, severe body aches, severe headache lasting about 9 hours starting at midnight following the vaccination.

Other Meds: Atorvastatin

Current Illness: None

ID: 1035777
Sex: F
Age: 31
State: NY

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 2/16/21 she dropped her cellphone while sitting down on chair after receiving her COVID vaccine .she felt dizzy, and fell down on floor while trying to pick up her cell phone.she denies that she hurt herself. BP was 55/44. No LOC . She had mild blurred vision for a couple of minutes. After placing her to a flat position on a couch, elevating her legs, and drinking water and juice, her BP improved to 110/86 p 90 Heart rate regular O2sat 98%. She went home with fianc? without dizziness or any medical issue 2/17 She reported arm and neck pain

Other Meds:

Current Illness:

ID: 1035778
Sex: F
Age: 50
State: MI

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: Na

Allergies: Bactrim Sulfa

Symptoms: Chills, hot flash, achy and weak about 18 hours Sore arm for 10 days Itchy red splotch below shot site started 5 days after and lasted 5-7 days

Other Meds: Ibuprofen Valerin

Current Illness: None

ID: 1035779
Sex: F
Age: 34
State: WI

Vax Date: 02/04/2021
Onset Date: 02/11/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: gluten, cats, grass, influenza vaccine

Symptoms: Left arm has itchy, quarter sized and dime sized raised red welts over injection site. No resolution as of 2/17.

Other Meds: l-lysine, prenatal vitamin, fluvoxamine, probiotic, pepcid

Current Illness:

ID: 1035780
Sex: F
Age: 69
State: ME

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None

Allergies: Unknown

Symptoms: No symptoms

Other Meds: Unknown

Current Illness: Unknown

ID: 1035781
Sex: F
Age: 75
State: NJ

Vax Date: 02/04/2021
Onset Date: 02/13/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None

Allergies: Augmenting

Symptoms: Red, itchy, swollen area at injection site 9 days after injection. No initial reaction to shot.

Other Meds: Simvastatin, vit. D, Femara, colace, vit.B complex,

Current Illness: On chemo treatments Dactyl, for uterine cancer.

ID: 1035782
Sex: M
Age: 54
State: MO

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: penicillin

Symptoms: Feeling very run down and tired.

Other Meds: Vitamin D, Calcium

Current Illness: none

ID: 1035783
Sex: F
Age: 43
State: AZ

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: None known

Symptoms: Headache, ears ringing, difficulty concentrating, arm incredibly sore.

Other Meds: Propranalol, Fluoxetine, Omeprezole, hydroxyzine,

Current Illness: none

ID: 1035784
Sex: F
Age: 33
State: TN

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 02/17/2021
Hospital: Y

Lab Data: 2/12/21 Ct with and without contrast 3 hour MRI of brain and spine with and without die Full stroke work up including swallow study Chest x-ray Troponin Lyme disease B12 CBC CRP All labs came back normal. Neurologist stated he wanted to make sure there was nothing else wrong before he said I had ?adverse neurological reaction to Pfizer?

Allergies: Latex

Symptoms: Received 2nd Pfizer dose on 2/5/21 at 0700. On 2/6/21 around 1930 temp was 102 took Tylenol at this time at 2200 temp was 103.7 took Advil at this time. Temp stayed 102-103.7 with Tylenol and Advil round the clock until 2/8/21 around 1300 at this time temp had gone down to 101. Noticed once fever started to drop my left toes started to tingle. Tingling got worse over the next few days until 2/11/21 my whole leg went extremely heavy (could not lift at all). Admitted to hospital 2/12/21.

Other Meds: None

Current Illness: None

ID: 1035785
Sex: F
Age: 0
State: IN

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pt received second dose of Moderna vaccine. Lot # 026L20A at 1420. Around 1425, patient experienced dizziness, lightheadedness, and warm feeling. Pt was given water, and monitored for 30 minutes. At that time, pt felt well, and left. No additional monitoring or interventions required.

Other Meds:

Current Illness:

ID: 1035786
Sex: F
Age: 65
State: FL

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None

Allergies: Allergic to Tetracycline, dust mites, some grasses.

Symptoms: About 10 hours after vaccination a headache started. Then my joints started hurting almost like a nerve was firing off but only at the joints, ie knee, shoulder, toes, ankle, fingers, toes, etc. It would happen randomly. Never all joints at once. Very weird. Continued throughout the night making it difficult to sleep. In the morning, at 7 am, got up out of bed. Took 2 Advil. At 10:20 I still have the joint happening but not as frequent and not as strong. I still have the headache. It hasn't changed.

Other Meds: On no prescriptions meds. One a day vitamin, Allegra-D 24hr, Glucosamine, vitamin D3 + K2, B-Complex

Current Illness: None

ID: 1035787
Sex: F
Age: 61
State: FL

Vax Date: 02/09/2021
Onset Date: 02/17/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: none

Allergies: none

Symptoms: painful itching started during the night around injection site, a week after receiving injection. slightly swollen, red rash about 1 1/2 inches in diameter. itching is continuous

Other Meds: Pravastatin Levothyroxine Metoprolol Bupropion mulivitamins

Current Illness: none

ID: 1035788
Sex: F
Age: 62
State: FL

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: Keflex

Symptoms: I received the first dose on 1/4/2021 in L arm and experienced some soreness only in arm for a day or so. I received the second dose on 2/1/2021 at 2:00 PM in L arm . . About 4 :00 I started to experience some soreness in arm By 6:00 PM the soreness went into the muscle on top of my shoulder and into that side of my neck . By 7;30 PM I could not move my arm and my entire arm was throbbing constantly . I began taking acetaminophen -500 mg every 4 hrs . I had to take 1000 mg to be able to sleep at 10:00 PM and was awaken from pain at 2:00 AM . The next day I still could not move my arm and continued acetaminophen every few hrs and applied ice . The discomfort finally went away on the afternoon of 2/3/2021 .

Other Meds: Fosomax - one time per week

Current Illness: none

ID: 1035789
Sex: F
Age: 75
State:

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: RE: COVID 19 vaccine Reaction 2-15-21 After receiving the Pfizer covid 19, dose 1, patient was having trouble breathing as she exited the clinic room. Outside the room patient was not able to get a breath, her escort kept her upright and called for help. Patient was moved into a wheelchair. I was called to assist. The patient had provided an epipen and felt her throat was closing. At this time, approximately 1350 I administered the Epipen. Shortly thereafter the patient was able to get air again. Her vitals were monitored for the next ~45 minutes and she progressively felt better. At this time the patient was offered and ER evaluation, but felt she was well enough to go home. She was transported by her husband and instructed to follow up with her PCP regarding the 2nd dose. I provided her with an epipen from our Emergency kit, as she did not have another one with her or at home. Vitals 1350 BP 169/74 HR 65 O2 97% 1400 BP 175/69 HR 64 O2 97% 1410 BP 156/68 HR 72 O2 83% 1420 168/63 HR 63 O2 97%

Other Meds:

Current Illness:

ID: 1035790
Sex: F
Age: 45
State: PA

Vax Date: 02/01/2021
Onset Date: 02/16/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None yet.

Allergies: Augmentin & latex

Symptoms: On Day 8 post vaccine injection, in the evening, my arm started to itch immensely at the injection site. I looked down and noticed what looked like hives beginning to develop around the immediate injection site. It quickly formed into a single raised "hive" covering the entire injection area, about the size of a quarter. It was and is extremely itchy and red. I marked the reaction site to monitor it. Today, Day 9 post vaccine, it continues to be extremely itchy and upon waking, the swelling has increased to roughly the size of a half dollar.

Other Meds: Vitamin D Effexor

Current Illness: Sinus infection

ID: 1035791
Sex: F
Age: 36
State: NC

Vax Date: 02/05/2021
Onset Date: 02/07/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: NKA

Symptoms: Delayed menstruation for 7 days Skin dryness on exterior of hand on same side of injection

Other Meds: N/A

Current Illness: N/A

ID: 1035792
Sex: F
Age: 74
State: AL

Vax Date: 01/08/2021
Onset Date: 02/17/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Are raised itching rash at injection site on day 10

Other Meds:

Current Illness:

ID: 1035793
Sex: F
Age: 58
State: CA

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: none

Allergies: none

Symptoms: I received my second dose 2/4/21. Approximately 24 hours following this dose I had a 102 fever, chills, head ache and stomach ache. Went to be and woke up the following day (2 days after the second dose) at 80% recovery and the next day (3 days after the second dose) at 100% recovery. A low grade head ach persisted for the next 7 days.

Other Meds: hormone replacements (all) and vitamin D

Current Illness: none

ID: 1035794
Sex: F
Age: 75
State: MI

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 02/17/2021
Hospital: Y

Lab Data:

Allergies: Macrobid Clindamycin Bactrim Cipro Oxycodone

Symptoms: Itchy eyes, followed by itching in her mouth and swelling of the back part of her tongue, trouble speaking and swallowing within minutes of receiving the COVID 19 Moderna vaccine. Sent to ER and admitted for overnight observation.

Other Meds: Chewable Aspirin Valsartan Prilosec Atenolol Cyanocobalamin

Current Illness: No

ID: 1035795
Sex: F
Age: 67
State: FL

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: non

Allergies: non

Symptoms: Very weak, fever 39.9, chills for three days

Other Meds: vitamins, Alendronate sodium

Current Illness: non

ID: 1035796
Sex: F
Age: 69
State: MN

Vax Date: 02/05/2021
Onset Date: 02/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: Amoxicillin Ceftin

Symptoms: Red patch itching and burning lump

Other Meds: Metformin Losartan Hydroclorizide Centrum silverD3 Aspirin 81 Metro pro lol Clonidine

Current Illness: Took a shingles shot 01-12-2021 2nd

ID: 1035797
Sex: F
Age: 87
State: AZ

Vax Date: 02/06/2021
Onset Date: 02/09/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: Brimonidine, tetracycline, vancomycin, bimatoprost

Symptoms: Lightheaded, general weakness; transported to ED via EMS due to inability to ambulate properly; given fluids and meclizine

Other Meds: apixaban, atorvastatin, bumex, carvedilol, clonidine, tylenol PM extra strength, ferrous sulfate, hydralazine, xalatan, melatonin, nifedipine, timolol, wheat dextrin

Current Illness:

ID: 1035798
Sex: F
Age: 38
State: MO

Vax Date: 01/29/2021
Onset Date: 02/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: N/A

Allergies: Colophony (rosin), nickel, gold Beef, chicken, seafood Strawberries, watermelon, cabbage Wheat, rye, oat All tested trees All tested grasses

Symptoms: Burning and itching sensation when feet are warm/sweating. 2/14 toes became red and swollen, . Light chest cough previous week, possibly unrelated.

Other Meds: Montelukast HTP-5 supplement Vitamin D Multivitamin Cranberry supplement

Current Illness: None

ID: 1035799
Sex: F
Age: 84
State: IN

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient received 2nd dose of Pfizer vaccine at around 1905. Started to have clammy, shortness of breath, and chest tightness. Progressively got worse. Vitals taken and were stable. BP 150/70. Oxygen 94% and HR 74. Epinephrine not given further evaluation done in the ER at 1930. Additional information: Unexpected. Patient was screened for potential side effects from previous dose prior and had no other allergies to our knowledge.

Other Meds:

Current Illness:

ID: 1035800
Sex: F
Age: 70
State: MI

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: none

Allergies: amoxicillin

Symptoms: woke up morning after shot with headache, slight nausea, severe muscle and joint pain and muscle weakness, could hardly sit up by myself, this was 2/11/21. I continued to feel these symptoms with lessening severity over the next 3 days until Sunday 2/14/21 at which time, late in the afternoon, I fell asleep and woke up drenched in sweat but feeling pretty much back to normal self and have felt normal self since then.

Other Meds: cellcept, prednisone, prozac, amlodipine, latanaprost, zinc, vitamin d, vitamin c

Current Illness: none

ID: 1035801
Sex: F
Age: 68
State: OH

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: None

Allergies: Sulfa, Ciprofloxacin, Cephalexin, Macrodanti, Bactrim

Symptoms: Chills, fever, aches, tiredness, headache, nausea, and sweats. Also injection site pain. Had to take a sick day from work. Started about 10 hours after the injection and lasted for about 26 hours. Took Ibuprofen and Advil for Migraine. Still have the headache and arm pain (48 hours after injection) but am able to work today.

Other Meds: Vitamin D, Calcium, Multi Vitamin, PARoxetine

Current Illness: none

ID: 1035802
Sex: F
Age: 26
State: SD

Vax Date: 02/08/2021
Onset Date: 02/15/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies: Azitheomycin Amoxicillin Sulfa Drugs Ceftriaxone

Symptoms: for 5 days, the arm had a red spot and itched. on days 6-7 it was gone, on days 8-10 (today) there is a red spot and is itchy

Other Meds: Birth Control Singulair

Current Illness: none

ID: 1035803
Sex: M
Age: 65
State: ID

Vax Date: 02/05/2021
Onset Date: 02/12/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Large rash, and itching.

Other Meds: Levothyroxine, Celaxa, atenolol, atorvastin, buspar, vitamin D, B12.

Current Illness:

ID: 1035804
Sex: M
Age: 71
State: VA

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: EKG

Allergies: no

Symptoms: pt stated that he always tracks his heart rate. Before taking the vax it was 75. After taking the vax his heart rate 111. He monitored it the entire day. He went to see his cardiologist the next day on 2/15/2021. At his doctor appt he was given a EKG. He did not have normal heart rhythm, he was having Atrial fibrillation . The doctor prescribed new medicine, metoprolol, for him to take along with the other medicine he is currently taking. Pt was told after taking this medicine if he wasn't back to a normal heart rate by 2/17/2021 to come back and he would a cardioversion. Pt went back to the doctor on 2/16/2021 to do another EKG and his heart rate was back down to 63. Doctor cut his the metoprolol dose in half and finish the prescription. He is scheduled to go back to the cardiologist on 3/15 which is the next day after his 2nd dose of covid vax.

Other Meds: Eliquis, Dofetilide

Current Illness: no

ID: 1035805
Sex: F
Age: 51
State: NY

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: n/a

Allergies: n/a

Symptoms: 3 1/2 hours after the shot exhausted (2/13), went to sleep and woke about 3 AM (2/14) with fever and chills, headache, nausea and injection site pain, body aches and muscle pain. This continued with fevers up to 101.3, which when treated with tylenol went to 99.8 for about 5 hours and went back to 101.3. Fevers were less 24 hours later (Monday 2/15) about 99, with some chills but less body ache but new cough and chest tightness (pulse ox was still 95). Site had red circle about 2 inches in diameter and was still painful, still had headache and nausea. body aches and pain had decreased, fatigue present throughout the whole time. Slept as much as possible from 2/13 until Monday 2/15, during that day had to sleep twice. little appetite and some nausea until 2/15 in the evening, when fever was finally gone. Toady, 2/17, still fatigued with slight headache.

Other Meds: Armour thyroid, vitamin D3, Vitamin B, Vitamin c

Current Illness: Covid, recovered 1/11/21

ID: 1035806
Sex: M
Age: 66
State: NY

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 02/17/2021
Hospital:

Lab Data: none

Allergies: Lisinopril, Keflex

Symptoms: 102F temperature, chills, headaches, tiredness, can't sleep at night. The headaches are weird in that I will get a sharp pain in my head that goes away in a second.

Other Meds: Metoprolol, 50 MG tablet Losartan Potassium, 50 MG tablet Baby Aspirin, 81 MG tablet Atorvistatin, 40 MG 3 times a week Optional Supplements Vitamin C, 500 MG tablet One Daily Men?s 50+ Multivitamin/Multimineral Supplement Microtabs

Current Illness: none

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm